ArticleDiabetes, obesity & metabolism2025

Risk of insulin initiation with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A real-world claims database study in Japan.

Ryo Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.